Integrated BioPharma, Inc. (OTCMKTS:INBP) Short Interest Update

Integrated BioPharma, Inc. (OTCMKTS:INBP) was the recipient of a large growth in short interest during the month of November. As of November 15th, there was short interest totalling 6,400 shares, a growth of 23.1% from the October 31st total of 5,200 shares. Based on an average daily trading volume, of 13,900 shares, the short-interest ratio is presently 0.5 days.

Integrated BioPharma Stock Down 1.2 %

Shares of OTCMKTS:INBP traded down $0.00 during midday trading on Monday, reaching $0.32. 20 shares of the company traded hands, compared to its average volume of 10,622. Integrated BioPharma has a 12 month low of $0.16 and a 12 month high of $0.35. The firm has a market capitalization of $9.63 million, a price-to-earnings ratio of 16.00 and a beta of 0.62. The firm’s fifty day moving average price is $0.29 and its two-hundred day moving average price is $0.24.

Integrated BioPharma (OTCMKTS:INBP) last released its quarterly earnings data on Friday, September 20th. The company reported $0.01 earnings per share (EPS) for the quarter. The company had revenue of $12.75 million for the quarter. Integrated BioPharma had a return on equity of 2.26% and a net margin of 0.84%.

About Integrated BioPharma

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.